Skin Hydration Sensor for Sickle Cell Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new skin hydration sensor to determine its accuracy in measuring hydration levels in individuals with sickle cell disease (SCD), a condition affecting red blood cells that can cause pain and other health issues. The sensor may help guide hydration therapy, crucial for managing SCD symptoms. Suitable participants are those diagnosed with sickle cell disease and aged 12 or older. As an unphased trial, this study allows participants to contribute to innovative research that could enhance hydration management in SCD.
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this skin hydration sensor is safe for use in patients with sickle cell disease?
Research shows that the skin hydration sensor is a wireless device that measures skin moisture. Soft and worn directly on the skin, it offers comfort and ease of use. Unlike traditional devices, this sensor uses heat to measure hydration.
Previous studies on similar sensors have indicated reliability and affordability. They perform well in various settings, suggesting safety and ease of use for different skin types.
No specific reports of negative effects from using these sensors have emerged, suggesting they are generally well-tolerated. However, as this trial aims to confirm the sensor's accuracy, more information may be needed to fully ensure its safety for individuals with sickle cell disease.12345Why are researchers excited about this trial?
Researchers are excited about the Skin Hydration Sensor for sickle cell disease because it offers a non-invasive way to monitor a critical aspect of the condition—hydration levels. Unlike traditional methods that might require blood tests or more intrusive measures, this sensor allows for continuous and real-time tracking of skin hydration. This can help in preventing crises by alerting patients and healthcare providers to dehydration risks earlier, potentially improving overall disease management and patient quality of life.
What evidence suggests that this skin hydration sensor is effective for assessing hydration in sickle cell disease?
Research has shown that skin hydration sensors can measure hydration levels in real time. These sensors use a technique called bioimpedance spectroscopy (BIS), which has proven accurate in tracking personal hydration. In this trial, participants will use the Skin Hydration Sensor to assess its effectiveness specifically for people with sickle cell disease (SCD). Early results suggest it could help guide hydration treatment. Proper hydration is crucial for SCD patients because it can help manage pain and other symptoms. Overall, this sensor could become a useful tool to improve care for individuals with SCD.35678
Who Is on the Research Team?
Enrico Novelli, MD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for individuals aged 12 or older who have been diagnosed with Sickle Cell Disease, including various genotypes like SS, SC, and others. Participants must be able to give legal consent to all study procedures. Those under 12 or currently in other clinical trials for experimental therapies cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants' skin hydration is measured at baseline state of health using the Delfin MoistureMeterEpiD hydration sensor.
Crisis Assessment
Skin hydration, serum osmolality, hyperadhesion, elongation index, point of sickling, and urine osmolality are measured before and after fluid resuscitation therapy during a vaso-occlusive crisis (VOC) or vaso-occlusive episode (VOE).
Follow-up
Participants are monitored for safety and effectiveness after the assessments.
What Are the Treatments Tested in This Trial?
Interventions
- Skin Hydration Sensor
Find a Clinic Near You
Who Is Running the Clinical Trial?
Enrico Novelli
Lead Sponsor
Enrico M Novelli
Lead Sponsor